164 related articles for article (PubMed ID: 35712990)
1. Recent advances in nanomaterials for prostate cancer detection and diagnosis.
Hu Y; Lv S; Wan J; Zheng C; Shao D; Wang H; Tao Y; Li M; Luo Y
J Mater Chem B; 2022 Jul; 10(26):4907-4934. PubMed ID: 35712990
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer biomarkers detection using nanoparticles based electrochemical biosensors.
Singh S; Gill AAS; Nlooto M; Karpoormath R
Biosens Bioelectron; 2019 Jul; 137():213-221. PubMed ID: 31100601
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. [Role of nanomaterials in the diagnosis of prostate cancer: An update].
Leng CJ; Hu J; Xu S
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):660-664. PubMed ID: 38619417
[TBL] [Abstract][Full Text] [Related]
5. Electrochemical prostate-specific antigen biosensors based on electroconductive nanomaterials and polymers.
Dowlatshahi S; Abdekhodaie MJ
Clin Chim Acta; 2021 May; 516():111-135. PubMed ID: 33545110
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation signatures of Prostate Cancer in peripheral T-cells.
Mehdi A; Cheishvili D; Arakelian A; Bismar TA; Szyf M; Rabbani SA
BMC Cancer; 2020 Jun; 20(1):588. PubMed ID: 32576165
[TBL] [Abstract][Full Text] [Related]
7. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
8. Influence of transrectal ultrasound probe on prostate cancer detection in transrectal ultrasound-guided sextant biopsy of prostate.
Paul R; Korzinek C; Necknig U; Niesel T; Alschibaja M; Leyh H; Hartung R
Urology; 2004 Sep; 64(3):532-6. PubMed ID: 15351585
[TBL] [Abstract][Full Text] [Related]
9. Advances in nanosensors for cardiovascular disease detection.
Tang X; Zhu Y; Guan W; Zhou W; Wei P
Life Sci; 2022 Sep; 305():120733. PubMed ID: 35777581
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in nanomaterials for colorimetric cancer detection.
Wang H; Wu T; Li M; Tao Y
J Mater Chem B; 2021 Jan; 9(4):921-938. PubMed ID: 33367450
[TBL] [Abstract][Full Text] [Related]
11. Assays for prostate cancer : changing the screening paradigm?
Hansen J; Rink M; Graefen M; Shariat S; Chun FK
Mol Diagn Ther; 2013 Feb; 17(1):1-8. PubMed ID: 23355098
[TBL] [Abstract][Full Text] [Related]
12. The present and future of prostate cancer urine biomarkers.
Rigau M; Olivan M; Garcia M; Sequeiros T; Montes M; Colás E; Llauradó M; Planas J; Torres Id; Morote J; Cooper C; Reventós J; Clark J; Doll A
Int J Mol Sci; 2013 Jun; 14(6):12620-49. PubMed ID: 23774836
[TBL] [Abstract][Full Text] [Related]
13. An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer.
Thambiraj S; Hema S; Shankaran DR
Recent Pat Nanotechnol; 2018; 12(2):110-131. PubMed ID: 29090672
[TBL] [Abstract][Full Text] [Related]
14. Glycosylated biomarker sensors: advancements in prostate cancer diagnosis.
Abd Rahman SF; Md Arshad MK; Gopinath SCB; Fathil MFM; Sarry F; Ibau C
Chem Commun (Camb); 2021 Sep; 57(76):9640-9655. PubMed ID: 34473143
[TBL] [Abstract][Full Text] [Related]
15. Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume.
Omri N; Kamil M; Alexander K; Alexander K; Edmond S; Ariel Z; David K; Gilad AE; Azik H
Prostate; 2020 Dec; 80(16):1444-1449. PubMed ID: 32970856
[TBL] [Abstract][Full Text] [Related]
16. Combined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate cancer biomarkers.
Zhang M; Chen L; Yuan Z; Yang Z; Li Y; Shan L; Yin B; Fei X; Miao J; Song Y
Discov Med; 2016 Nov; 22(122):281-295. PubMed ID: 28009970
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
18. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
19. Current state of biomarkers for the diagnosis and assessment of treatment efficacy of prostate cancer.
Liu J; Li Y; Yang D; Yang C; Mao L
Discov Med; 2019 Jun; 27(150):235-243. PubMed ID: 31421692
[TBL] [Abstract][Full Text] [Related]
20. Novel Diagnostic Biomarkers of Prostate Cancer: An Update.
Anceschi U; Tuderti G; Lugnani F; Biava PM; Malossini G; Luciani L; Cai T; Marsiliani D; Filianoti A; Mattevi D; Costantini M; Misuraca L; Simone G
Curr Med Chem; 2019; 26(6):1045-1058. PubMed ID: 30215331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
